Surgical Robotics
Welcome to MassDevice's Surgical Robotics Hub, your resource for the latest news and insights on all things robotic surgery. Stay informed about the innovations and business news shaping the industry.
🤖 Narrow your focus with these categories:
Robot-Assisted
Here are top surgical robotic features from MassDevice and its sister publications (and scroll down to read the latest cardiology device news from MassDevice):
+ Intuitive details da Vinci 5 launch plans with limited supply of next-gen surgical robotics systems
+ 10 surgical robotics companies you need to know
+ The secret behind Intuitive’s surgical robotics success
+ Surgical robotics trends and how to accelerate adoption
+ How surgical robotics safety systems prevent patient harm
+ These surgical robotics arms are destined for the trash — by design
Latest Surgical Robotics News
Stereotaxis escapes all shareholder lawsuits
Surgical robotics maker Stereotaxis (NSDQ:STXS) announced week that it’s officially clear of all shareholder litigation after a pair of lawsuits quietly closed this year.
Hansen Medical doubles Q2 sales, draws $23M from warrants
Report: Surgical robots may be moot in cystectomy
The much-disputed field of robot-assisted surgery took another blow this week when doctors from Memorial Sloan Kettering Cancer Center warned that the high-tech procedure may be no better than traditional surgery for patients with invasive bladder cancer.
Intuitive Surgical’s Q2 profits tank but still beat expectations
California device maker Intuitive Surgical (NSDQ:ISRG) got a major after-hours boost after reporting Q2 numbers that, while still down year-over-year, beat Wall Street’s expectations by a mile.
Medrobotics’ surgical robot premiers in Germany
Medtech maker Medrobotics celebrated the world’s 1st cancer surgeries performed with its Flex surgical robot in a pair of procedures conducted at a hospital in Germany.
Study: Mazor touts 99% accuracy in placing screws in youth with scoliosis
Study: Robot prostatectomy looks good at 10 years
Robot-assisted radical prostatectomy (RARP) proved just as good as open surgery in keeping the prostate cancer under control for 10 years following the procedure, according to a new study from researchers at the Henry Ford Hospital.
Nearly 99% of the RARP patients enrolled in the study survived cancer for a decade following surgery and about 73% were recurrence-free and 97.5% of the group was metastasis-free, according to the report.
Appeals court upholds Intuitive Surgical’s win in shareholders lawsuit
Robot surgery becomes a poster child for curbing new health tech
Exo-suit maker ReWalk files for $57.5M IPO
ReWalk Robotics, formerly Argo Medical Technologies, is preparing an initial public offering worth up to $57.5 million, according to regulatory filings.